Skip to main content

and
  1. Article

    Open Access

    Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry

    Numerous studies have reported clinical endpoints following coronary revascularization using bioresorbable vascular scaffolds (BVS), while information about the impact on health-related quality of life is spar...

    Kathrin Pahmeier, Silke Neusser, Christian Hamm in BMC Cardiovascular Disorders (2022)

  2. No Access

    Article

    Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

    The purpose of this study was to compare the clinical outcomes of patients treated with bioresorbable scaffold (BRS) for off-label versus approved indications.

    Aydin Huseynov, Stefan Baumann, Holger Nef in Clinical Research in Cardiology (2020)